Pharmacyte Biotech Inc (PMCB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 04/30
(Values in U.S. thousands)
| 04-2011 | 04-2010 | 04-2009 | 04-2007 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 57 | 1 | 0 | N/A |
| Receivables | 2 | 10 | 0 | N/A |
| Inventories | 19 | 3 | 0 | N/A |
| Other current assets | 0 | -4 | 0 | 0 |
| TOTAL | $105 | $10 | $0 | $N/A |
| Non-Current Assets | ||||
| PPE Net | 107 | 100 | 0 | N/A |
| Other Non-Current Assets | 1,029 | 1,080 | 0 | 0 |
| TOTAL | $1,135 | $1,180 | $N/A | $N/A |
| Total Assets | $1,240 | $1,200 | $0 | $N/A |
| Liabilities | ||||
| Current Liabilities | ||||
| Short Term Debt | 2,372 | 2,280 | 0 | N/A |
| Accounts payable and accrued liabilities | 743 | 670 | 0 | 0 |
| Accrued Expenses | 274 | 90 | 0 | N/A |
| TOTAL | $3,390 | $3,050 | $0 | $N/A |
| Non-Current Liabilities | ||||
| Long Term Debt | N/A | 100 | 0 | N/A |
| TOTAL | $N/A | $100 | $N/A | $N/A |
| Total Liabilities | $3,390 | $3,150 | $0 | $N/A |
| Shareholders' Equity | ||||
| Common Shares | 36 | 30 | 0 | N/A |
| Retained earnings | -37,949 | -36,550 | 0 | N/A |
| Other shareholders' equity | 768 | 510 | 0 | 0 |
| TOTAL | $-2,149 | $-1,950 | $0 | $N/A |
| Total Liabilities And Equity | $1,240 | $1,200 | $0 | $0 |